参考文献/References:
[1] CHEN L R,YAO J P,ZHANG Y Z,ZHOU N,GAO B.Clinical significance of calcium hydroxide combined with GLP-1 in the treatment of diabetic retinopathy[J].Chin J Hosp Pharm,2017,37(15):1505-1508.
陈利荣,姚军平,张贻转,周宁,高波.羟苯磺酸钙联合GLP-1类似物治疗糖尿病视网膜病变的临床意义[J].中国医院药学杂志,2017,37(15):1505-1508.
[2] SIMO R,HERNANDEZ C.Neurodegeneration is an early event in diabetic retinopathy:therapeutic implications[J].Br J Ophthalmol,2012,96(10):1285-1290.
[3] LEI Y,ZHENG H H,CHEN X H,MEI X,CHEN M Z.Research advance in GLP-1 for the treatment of diabetic retinopathy[J].Rec Adv Ophthalmol,2017,37(12):1193-1196.
雷雨,郑宏华,陈小红,梅雪,陈梅珠.GLP-1防治糖尿病视网膜病变的研究进展[J].眼科新进展,2017,37(12):1193-1196.
[4] CAMPBELL J E,DRUCKER D J.Pharmacology,physiology,and mechanisms of incretin hormone action[J].Cell Metab,2013,17(6):819-837.
[5] PYKE C,HELLER R S,KIRK R K,ORSKOV C,REEDTZ-RUNGE S,KAASTRUP P,et al.GLP-1 receptor localization in monkey and human tissue:novel distribution revealed with extensively validated monoclonal antibody[J].Endocrinology,2014,155(4):1280-1290.
[6] HERNANDEZ C,BOGDANOV P,CORRALIZA L,GARCIA-RAMI-REZ M,SOLA-ADELL C,ARRANZ J A,et al.Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes[J].Diabetes,2016,65(1):172-187.
[7] HEINE R J,VAN G L F,JOHNS D,MIHM M J,WIDEL M H,BRODOWS R G,et al.Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes:a randomized trial[J].Ann Intern Med,2005,143(8):559-569.
[8] VARANASI A,CHAUDHURI A,DHINDSA S,ARORA A,LOHANO T,VORA M,et al.Durability of effects of exenatide treatment on glycaemic control,body weight,systolic blood pressure,Crp and triglyceride concentrations[J].Endocr Pract,2011,17(2):192-200.
[9] WILKINSON C P,FERRIS F L 3rd,KLEIN R E,LEE P P,AGARDH C D,DAVIS M,et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1677-1682.
[10] REDDY M A,ZHANG E,NATARAJAN R.Epigenetic mechanisms in diabetic complications and metabolic memory[J].Diabetologia,2015,58(3):443-455.
[11] BEREZIN A.Metabolic memory phenomenon in diabetes mellitus:Achieving and perspectives[J].Diabetes Metab Syndr,2016,10(2):176-183.
[12] HOLST J J.Glucagon-like peptide-1:from extract to agent.The claude bernard lecture,2005[J].Diabetologia,2006,49(2):253-260.
[13] GONCALVES A,LIN C M,MUTHUSAMY A,FONTES-RIBEIRO C,AMBROSIO A F,ABCOUWER S F,et al.Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation[J].Invest Ophthalmol Vis Sci,2016,57(6):2584-2592.
[14] FAN Y C,LIU K,WANG Q P,RUAN Y Y,YE W,ZHANG Y.Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic goto-kakizaki rats [J].Exp Eye Res,2014,127(10):104-116.
[15] SHIN S,LE L J,EVERETT L J,GUPTA R,RAFIQ K,KAESTNER K H.CREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse beta-cells[J].Mol Metab,2014,3(8):803-812.
[16] AGARWAL P,JINDAL A,SAINI V K,JINDAL S.Advances in diabetic retinopathy[J].IJEM,2014,18(6):772.
[17] BARBER A J.A new view of diabetic retinopathy:a neurodegenerative disease of the eye[J].Prog Neuropsychopharmacol Biol Psych,2003,27(2):283-290.
[18] SIMO R,HERNANDEZ C.Neurodegeneration in the diabetic eye:new insights and therapeutic perspectives[J].Trends Endocrinol Metab,2014,25(1):23-33.
[19] KANG P,LU H,WANG Z F,LI K J,YAO X.Comparative study of oscillatory potentials in electroretinogram and fluorescein fundus angiography in patients with diabetic retinopathy[J].Ophthalmol CHN,2010,19(4):283-284.
康平,路晖,王作芬,李凯军,姚雪.糖尿病视网膜病变患者视网膜电图震荡电位与荧光素眼底血管造影的对比研究[J].眼科,2010,19(4):283-284.
[20] KAWASAKI K.Preretinopathic changes in the oscillatory potential in diabetic retina:interpretation and significance[J].Nihon Ganka Gakkai Zasshi,1998,102(12):813-836.
[21] FANG Y H,ZHANG X D,LEI B.Research progress of oscillatory potentials in electroretinogram and its application in diabetic retinopathy[J].Chin J Ocul Fundus Dis,2013,29(1):106-108.
方晏红,张学东,雷博.视网膜电图震荡电位的研究进展及其在糖尿病视网膜病变中的应用[J].中华眼底病杂志,2013,29(1):106-108.
[22] VADALA M,ANASTASI M,LODATO G,CILLINO S.Electroretinographic oscillatory potentials in insulin-dependent diabetes patients:a long-term follow-up[J].Acta Ophthalmol Scand,2002,80(3):305-309.
[23] HANCOCK H A,KRAFT T W,OSCILLATOR Y.Potential analysis and ERGs of normal and diabetic rats[J].Invest Ophthalmol Vis Sci,2004,45(3):1002-1008.
[24] MARMOR M F,FULTON A B,HOLDER G E,MIYAKE Y,BRIGELL M,BACH M.ISCEV standard for full-field clinical electroretinography (2008 update)[J].Doc Ophthalmol,2009,118(1):69-77.
[25] LANG G E.Diabetic macular edema[J].Ophthalmologica,2012,227(suppl 1):21-29.
相似文献/References:
[1]曲申 徐蔚 孙小婷 毕燕龙 荣翱.Cirrus HD-OCT测量黄斑区视网膜厚度的可重复性研究[J].眼科新进展,2012,32(12):000.
[2]陈家欣,吴瑜瑜. 全视网膜光凝术对糖尿病视网膜病变视网膜神经纤维层及黄斑区视网膜的影响[J].眼科新进展,2015,35(4):380.[doi:10.13389/j.cnki.rao.2015.0103]
CHEN Jia-Xin,WU Yu-Yu. Effects of panretinal photocoagulation on retinal nerve fiber layer and macular retina in patients with diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(7):380.[doi:10.13389/j.cnki.rao.2015.0103]